Abstract
The Alzheimer's disease related peptide amyloid beta (Abeta) might have a physiological role in upregulating K channel currents in neurones. Earlier studies used the human form of Abeta1-40 on rat neurones. We sought to confirm our hypothesis by use of rat Abeta, which has no Alzheimer's association. In rat cerebellar granule neurones and HEK293 cells expressing Kv4.2 subunits, whole-cell patch clamp of K currents revealed that preincubation of cells with recombinant human or rat Abeta1-40 (10 nM for 24 h) significantly increased K channel current density. This was accompanied by increased mRNA levels for Kv4.2. These data indicate that rodent and human Abeta are effective in modulating K currents. The effectiveness of nonaggregating rat Abeta also strongly supports a physiological role for the peptide.
| Original language | English |
|---|---|
| Pages (from-to) | 839-43 |
| Number of pages | 5 |
| Journal | NeuroReport |
| Volume | 19 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 28 May 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Amyloid beta-Peptides
- Animals
- Cell Line
- Cerebellum
- Humans
- Ion Channel Gating
- Kidney
- Neurons
- Patch-Clamp Techniques
- Peptide Fragments
- Potassium
- RNA, Messenger
- Rats
- Recombinant Proteins
- Shal Potassium Channels
Fingerprint
Dive into the research topics of 'Modulation of 'A'-type K+ current by rodent and human forms of amyloid beta protein'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver